Westerink, Lotte http://orcid.org/0000-0001-9515-1044
Nicolai, Jelmer Lennart Jens
Postma, Maarten Jacobus http://orcid.org/0000-0002-6306-3653
van Boven, Job Frank Martien http://orcid.org/0000-0003-2368-2262
Boersma, Cornelis http://orcid.org/0000-0002-1190-2638
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Accepted: 7 July 2022
First Online: 4 August 2022
Declarations
:
: This study was funded by Boehringer Ingelheim.
: CB received grants and honoraria from various pharmaceutical companies, including other companies interested in the subject of this paper. JB received consultancy fees, honorarium and research funding from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Menarini, Novartis, Pfizer, Teva and Trudell Medical to consult, give lectures, provide advice and conduct independent research, all paid to his institution. MP received grants and honoraria from various pharmaceutical companies, including other companies interested in the subject of this paper. LW is an employee of Asc Academics. JN is an employee of Boehringer Ingelheim.
: All authors made substantial contributions to the conception, design and analysis of the work and the data. LW drafted and JB, CB, MP and JN revised the work. All authors approved the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
: Not applicable.
: Not applicable.
: Not applicable.
: All data generated or analysed during this study are included in this published article (and its supplementary information files).
: Not applicable.